Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
Phathom Pharmaceuticals (PHAT) Ownership Overview
8.99% Insiders
10.20% Mutual Funds
47.25% Other Institutional Investors
8.18% ETFs
25.39% Public Companies and
Individual Investors
The ownership structure of Phathom Pharmaceuticals (PHAT) stock is a mix of institutional, retail, and individual investors. Approximately 65.62% of the company’s stock is owned by Institutional Investors, 8.99% is owned by Insiders, and 25.39% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Nov 05, 2025 | xxxxxxxxxxxxx | $7079 | |
Sep 09, 2025 | xxxxxxxxxxxxx | $5573 | |
Jul 18, 2025 | xxxxxxxxxxxxx | $14145 | |
May 23, 2025 | xxxxxxxxxxxxx | $14591 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $213463 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $2408436 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $2438730 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,933,327 | Insider | 7.53% | 61,943,934 | |
| 2,915,693 | Institution | 3.70% | 30,439,835 | |
| 2,313,296 | Institution | 2.94% | 24,150,810 | |
| 2,090,042 | Institution | 2.65% | 21,820,038 | |
| 1,312,577 | Institution | 1.67% | 13,703,304 | |
| 746,710 | Institution | 0.95% | 7,795,652 | |
| 626,862 | Institution | 0.80% | 6,544,439 | |
| 600,000 | Institution | 0.76% | 6,264,000 | |
| 480,090 | Institution | 0.61% | 5,012,140 | |
| 465,715 | Institution | 0.59% | 4,862,065 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,313,296 | Institution | 2.94% | 24,150,810 | |
| 1,312,577 | Institution | 1.67% | 13,703,304 | |
| 746,710 | Institution | 0.95% | 7,795,652 | |
| 626,862 | Institution | 0.80% | 6,544,439 | |
| 480,090 | Institution | 0.61% | 5,012,140 | |
| 465,715 | Institution | 0.59% | 4,862,065 | |
| 464,839 | Institution | 0.59% | 4,852,919 | |
| 262,589 | Institution | 0.33% | 2,741,429 | |
| 240,680 | Institution | 0.31% | 2,512,699 | |
| 221,065 | Institution | 0.28% | 2,307,919 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,961,598 | Institution | 2.49% | 26,815,045 | |
| 953,923 | Institution | 1.21% | 9,892,182 | |
| 493,906 | Institution | 0.63% | 6,751,695 | |
| 371,741 | Institution | 0.47% | 3,854,954 | |
| 334,252 | Institution | 0.42% | 3,466,193 | |
| 291,540 | Institution | 0.37% | 3,043,678 | |
| 247,556 | Institution | 0.31% | 2,567,156 | |
| 220,832 | Institution | 0.28% | 2,290,028 | |
| 196,864 | Institution | 0.25% | 2,472,612 | |
| 182,692 | Institution | 0.23% | 1,894,516 |
FAQ
Who Owns Phathom Pharmaceuticals (PHAT)?
According to the latest TipRanks data, approximately 47.25% of the company's stock is held by institutional investors, 8.99% is held by insiders, and 25.39% is held by retail investors.
What percentage of Phathom Pharmaceuticals (PHAT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 47.25% of Phathom Pharmaceuticals (PHAT) stock is held by institutional investors.
What percentage of Phathom Pharmaceuticals (PHAT) stock is held by retail investors?
According to the latest TipRanks data, approximately 25.39% of Phathom Pharmaceuticals (PHAT) stock is held by retail investors.
Who owns the most shares of Phathom Pharmaceuticals (PHAT)?
James Topper owns the most shares of Phathom Pharmaceuticals (PHAT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.